{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:26:08Z","timestamp":1793964368458,"version":"4.8.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["201709FDN-CEBA-116200 to GS"],"award-info":[{"award-number":["201709FDN-CEBA-116200 to GS"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013528","name":"Diabetes Canada","doi-asserted-by":"publisher","award":["DI-5-17-5302-GS"],"award-info":[{"award-number":["DI-5-17-5302-GS"]}],"id":[{"id":"10.13039\/100013528","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"DOI":"10.1038\/s42255-019-0146-4","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T12:02:28Z","timestamp":1575892948000},"page":"1202-1208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":292,"title":["Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss"],"prefix":"10.1038","volume":"1","author":[{"given":"Emily A.","family":"Day","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brennan K.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedrum","family":"Mohammadi-Shemirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa R.","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Gutgesell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9259-5280","authenticated-orcid":false,"given":"Amogelang R.","family":"Raphenya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Kabiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"McArthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"McInnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Par\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hertzel C.","family":"Gerstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5425-8275","authenticated-orcid":false,"given":"Gregory R.","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,9]]},"reference":[{"key":"146_CR1","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1007\/s00125-013-2991-0","volume":"56","author":"G Rena","year":"2013","unstructured":"Rena, G., Pearson, E. R. & Sakamoto, K. Molecular mechanism of action of metformin: old or new insights? Diabetologia 56, 1898\u20131906 (2013).","journal-title":"Diabetologia"},{"key":"146_CR2","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","volume":"20","author":"M Foretz","year":"2014","unstructured":"Foretz, M., Guigas, B., Bertrand, L., Pollak, M. & Viollet, B. Metformin: from mechanisms of action to therapies. Cell Metab. 20, 953\u2013966 (2014).","journal-title":"Cell Metab."},{"key":"146_CR3","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","volume":"60","author":"G Rena","year":"2017","unstructured":"Rena, G., Hardie, D. G. & Pearson, E. R. The mechanisms of action of metformin. Diabetologia 60, 1577\u20131585 (2017).","journal-title":"Diabetologia"},{"key":"146_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2337\/dbi17-0039","volume":"67","author":"GR Steinberg","year":"2018","unstructured":"Steinberg, G. R. Cellular energy sensing and metabolism\u2014implications for treating diabetes: The 2017 outstanding scientific achievement award lecture. Diabetes 67, 169\u2013179 (2018).","journal-title":"Diabetes"},{"key":"146_CR5","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.cmet.2016.03.010","volume":"23","author":"NS Chandel","year":"2016","unstructured":"Chandel, N. S. et al. Are metformin doses used in murine cancer models clinically relevant? Cell Metab. 23, 569\u2013570 (2016).","journal-title":"Cell Metab."},{"issue":"9","key":"146_CR6","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1038\/s41591-018-0125-4","volume":"24","author":"Anila K. Madiraju","year":"2018","unstructured":"Madiraju, A. K. et al. Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo. Nat. Med. 24, 1384\u20131394 (2018).","journal-title":"Nature Medicine"},{"key":"146_CR7","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.2337\/db16-0032","volume":"65","author":"JB Jensen","year":"2016","unstructured":"Jensen, J. B. et al. [11C]-labeled metformin distribution in the liver and small intestine using dynamic positron emission tomography in mice demonstrates tissue-specific transporter dependency. Diabetes 65, 1724\u20131730 (2016).","journal-title":"Diabetes"},{"key":"146_CR8","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.2967\/jnumed.116.177774","volume":"57","author":"LC Gormsen","year":"2016","unstructured":"Gormsen, L. C. et al. In vivo imaging of human 11C-metformin in peripheral organs: dosimetry, biodistribution, and kinetic analyses. J. Nucl. Med. 57, 1920\u20131926 (2016).","journal-title":"J. Nucl. Med."},{"key":"146_CR9","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.2337\/dc09-1284","volume":"33","author":"A Frid","year":"2010","unstructured":"Frid, A. et al. Novel assay of metformin levels in patients with type 2 diabetes and varying levels of renal function: clinical recommendations. Diabetes Care 33, 1291\u20131293 (2010).","journal-title":"Diabetes Care"},{"key":"146_CR10","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/s41591-018-0159-7","volume":"24","author":"RW Hunter","year":"2018","unstructured":"Hunter, R. W. et al. Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase. Nat. Med. 24, 1395\u20131406 (2018).","journal-title":"Nat. Med."},{"key":"146_CR11","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/nm.3372","volume":"19","author":"MD Fullerton","year":"2013","unstructured":"Fullerton, M. D. et al. Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin. Nat. Med. 19, 1649\u20131654 (2013).","journal-title":"Nat. Med."},{"key":"146_CR12","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nature15766","volume":"528","author":"K Forslund","year":"2015","unstructured":"Forslund, K. et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528, 262\u2013266 (2015).","journal-title":"Nature"},{"key":"146_CR13","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/nm.4345","volume":"23","author":"H Wu","year":"2017","unstructured":"Wu, H. et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat. Med. 23, 850\u2013858 (2017).","journal-title":"Nat. Med."},{"key":"146_CR14","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nm.3787","volume":"21","author":"FA Duca","year":"2015","unstructured":"Duca, F. A. et al. Metformin activates a duodenal Ampk\u2013dependent pathway to lower hepatic glucose production in rats. Nat. Med. 21, 506\u2013511 (2015).","journal-title":"Nat. Med."},{"key":"146_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00125-010-1937-z","volume":"54","author":"A Maida","year":"2011","unstructured":"Maida, A., Lamont, B. J., Cao, X. & Drucker, D. J. Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-\u03b1 in mice. Diabetologia 54, 339\u2013349 (2011).","journal-title":"Diabetologia"},{"key":"146_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/sj.ijo.0803695","volume":"32","author":"A Golay","year":"2008","unstructured":"Golay, A. Metformin and body weight. Int. J. Obes. 32, 61\u201372 (2008).","journal-title":"Int. J. Obes."},{"key":"146_CR17","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2337\/dc11-1299","volume":"35","author":"Diabetes Prevention Program Research Group.","year":"2012","unstructured":"Diabetes Prevention Program Research Group. Long-term safety, tolerability, and weight loss associated with metformin in the Diabetes Prevention Program Outcomes Study. Diabetes Care 35, 731\u2013737 (2012).","journal-title":"Diabetes Care"},{"key":"146_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/j.1550-8528.1998.tb00314.x","volume":"6","author":"A Lee","year":"1998","unstructured":"Lee, A. & Morley, J. E. Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes. Obes. Res. 6, 47\u201353 (1998).","journal-title":"Obes. Res."},{"key":"146_CR19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2337\/db16-0915","volume":"66","author":"Q Wang","year":"2017","unstructured":"Wang, Q. et al. Metformin suppresses diabetes-accelerated atherosclerosis via the inhibition of Drp1-mediated mitochondrial fission. Diabetes 66, 193\u2013205 (2017).","journal-title":"Diabetes"},{"key":"146_CR20","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s12020-018-1717-y","volume":"62","author":"H-H Ning","year":"2018","unstructured":"Ning, H.-H. et al. The effects of metformin on simple obesity: a meta-analysis. Endocrine 62, 528\u2013534 (2018).","journal-title":"Endocrine"},{"key":"146_CR21","doi-asserted-by":"publisher","first-page":"e0207947","DOI":"10.1371\/journal.pone.0207947","volume":"13","author":"M Solym\u00e1r","year":"2018","unstructured":"Solym\u00e1r, M. et al. Metformin induces significant reduction of body weight, total cholesterol and LDL levels in the elderly - a meta-analysis. PLoS ONE 13, e0207947 (2018).","journal-title":"PLoS ONE"},{"key":"146_CR22","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1056\/NEJM199508313330903","volume":"333","author":"M Stumvoll","year":"1995","unstructured":"Stumvoll, M., Nurjhan, N., Perriello, G., Dailey, G. & Gerich, J. E. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 333, 550\u2013554 (1995).","journal-title":"N. Engl. J. Med."},{"key":"146_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.physbeh.2013.01.011","volume":"110\u2013111","author":"H-J Kim","year":"2013","unstructured":"Kim, H.-J. et al. Metformin decreases meal size and number and increases c-Fos expression in the nucleus tractus solitarius of obese mice. Physiol. Behav. 110\u2013111, 213\u2013220 (2013).","journal-title":"Physiol. Behav."},{"key":"146_CR24","doi-asserted-by":"publisher","first-page":"bav077","DOI":"10.1093\/database\/bav077","volume":"2015","author":"J Meinken","year":"2015","unstructured":"Meinken, J., Walker, G., Cooper, C. R. & Min, X. J. MetazSecKB: the human and animal secretome and subcellular proteome knowledgebase. Database 2015, bav077 (2015).","journal-title":"Database"},{"key":"146_CR25","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1210\/jc.2016-3373","volume":"102","author":"N McInnes","year":"2017","unstructured":"McInnes, N. et al. Piloting a remission strategy in type 2 diabetes: results of a randomized controlled trial. J. Clin. Endocrinol. Metab. 102, 1596\u20131605 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"146_CR26","doi-asserted-by":"crossref","unstructured":"Patel, S. et al. GDF15 provides an endocrine signal of nutritional stress in mice and humans. Cell Metab. 29, 707\u2013718 (2019).","DOI":"10.1016\/j.cmet.2018.12.016"},{"key":"146_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature24042","volume":"550","author":"J-Y Hsu","year":"2017","unstructured":"Hsu, J.-Y. et al. Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15. Nature 550, 255\u2013259 (2017).","journal-title":"Nature"},{"key":"146_CR28","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/nm.4392","volume":"23","author":"SE Mullican","year":"2017","unstructured":"Mullican, S. E. et al. GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates. Nat. Med. 23, 1150\u20131157 (2017).","journal-title":"Nat. Med."},{"key":"146_CR29","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/nm.4393","volume":"23","author":"PJ Emmerson","year":"2017","unstructured":"Emmerson, P. J. et al. The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL. Nat. Med. 23, 1215\u20131219 (2017).","journal-title":"Nat. Med."},{"key":"146_CR30","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/nm.4394","volume":"23","author":"L Yang","year":"2017","unstructured":"Yang, L. et al. GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand. Nat. Med. 23, 1158\u20131166 (2017).","journal-title":"Nat. Med."},{"key":"146_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1242\/dmm.008110","volume":"5","author":"T Quentin","year":"2012","unstructured":"Quentin, T., Steinmetz, M., Poppe, A. & Thoms, S. Metformin differentially activates ER stress signaling pathways without inducing apoptosis. Dis. Model. Mech. 5, 259\u2013269 (2012).","journal-title":"Dis. Model. Mech."},{"key":"146_CR32","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.bbrc.2013.09.026","volume":"440","author":"KH Kim","year":"2013","unstructured":"Kim, K. H. et al. Metformin-induced inhibition of the mitochondrial respiratory chain increases FGF21 expression via ATF4 activation. Biochem. Biophys. Res. Commun. 440, 76\u201381 (2013).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"146_CR33","doi-asserted-by":"publisher","first-page":"280","DOI":"10.2337\/dc16-1682","volume":"40","author":"HC Gerstein","year":"2017","unstructured":"Gerstein, H. C. et al. Growth differentiation factor 15 as a novel biomarker for metformin. Diabetes Care 40, 280\u2013283 (2017).","journal-title":"Diabetes Care"},{"key":"146_CR34","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/dom.13519","volume":"21","author":"A Natali","year":"2019","unstructured":"Natali, A. et al. Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes: a nested, case-control study. Diabetes Obes. Metab. 21, 412\u2013416 (2019).","journal-title":"Diabetes Obes. Metab."},{"key":"146_CR35","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/ijo.2014.27","volume":"38","author":"K Chrysovergis","year":"2014","unstructured":"Chrysovergis, K. et al. NAG-1\/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism. Int. J. Obes. (Lond.) 38, 1555\u20131564 (2014).","journal-title":"Int. J. Obes. (Lond.)"},{"key":"146_CR36","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/nm1677","volume":"13","author":"H Johnen","year":"2007","unstructured":"Johnen, H. et al. Tumor-induced anorexia and weight loss are mediated by the TGF-\u03b2 superfamily cytokine MIC-1. Nat. Med. 13, 1333\u20131340 (2007).","journal-title":"Nat. Med."},{"key":"146_CR37","first-page":"641851","volume":"2013","author":"JM Kim","year":"2013","unstructured":"Kim, J. M. et al. NAG-1\/GDF15 transgenic mouse has less white adipose tissue and a reduced inflammatory response. Mediators Inflamm. 2013, 641851 (2013).","journal-title":"Mediators Inflamm."},{"key":"146_CR38","doi-asserted-by":"publisher","first-page":"e55174","DOI":"10.1371\/journal.pone.0055174","volume":"8","author":"VW-W Tsai","year":"2013","unstructured":"Tsai, V. W.-W. et al. TGF-b superfamily cytokine MIC-1\/GDF15 is a physiological appetite and body weight regulator. PLoS ONE 8, e55174 (2013).","journal-title":"PLoS ONE"},{"key":"146_CR39","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1210\/en.2008-0952","volume":"150","author":"Q Ding","year":"2009","unstructured":"Ding, Q. et al. Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes. Endocrinology 150, 1688\u20131696 (2009).","journal-title":"Endocrinology"},{"key":"146_CR40","doi-asserted-by":"publisher","first-page":"e34868","DOI":"10.1371\/journal.pone.0034868","volume":"7","author":"L Macia","year":"2012","unstructured":"Macia, L. et al. Macrophage inhibitory cytokine 1 (MIC-1\/GDF15) decreases food intake, body weight and improves glucose tolerance in mice on normal & obesogenic diets. PLoS ONE 7, e34868 (2012).","journal-title":"PLoS ONE"},{"key":"146_CR41","doi-asserted-by":"publisher","first-page":"6S44","DOI":"10.1016\/S1262-3636(03)72787-6","volume":"29","author":"PJ Grant","year":"2003","unstructured":"Grant, P. J. Beneficial effects of metformin on haemostasis and vascular function in man. Diabetes Metab. 29, 6S44\u20136S52 (2003).","journal-title":"Diabetes Metab."},{"key":"146_CR42","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cmet.2016.05.011","volume":"23","author":"N Barzilai","year":"2016","unstructured":"Barzilai, N., Crandall, J. P., Kritchevsky, S. B. & Espeland, M. A. Metformin as a tool to target aging. Cell Metab. 23, 1060\u20131065 (2016).","journal-title":"Cell Metab."},{"key":"146_CR43","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1074\/jbc.M109.056762","volume":"285","author":"N Dzamko","year":"2010","unstructured":"Dzamko, N. et al. AMPK 1 deletion reduces appetite, preventing obesity and hepatic insulin resistance. J. Biol. Chem. 285, 115\u2013122 (2010).","journal-title":"J. Biol. Chem."},{"key":"146_CR44","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1101\/gad.12.7.982","volume":"12","author":"H Zinszner","year":"1998","unstructured":"Zinszner, H. et al. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev. 12, 982\u2013995 (1998).","journal-title":"Genes Dev."},{"key":"146_CR45","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ebiom.2019.08.041","volume":"47","author":"WN Leonhard","year":"2019","unstructured":"Leonhard, W. N. et al. Salsalate, but not metformin or canagliflozin, slows kidney cyst growth in an adult-onset mouse model of polycystic kidney disease. EBioMedicine 47, 436\u2013445 (2019).","journal-title":"EBioMedicine"},{"key":"146_CR46","doi-asserted-by":"publisher","first-page":"374","DOI":"10.2144\/03342mt01","volume":"34","author":"AI Saeed","year":"2003","unstructured":"Saeed, A. I. et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34, 374\u2013378 (2003).","journal-title":"Biotechniques"},{"key":"146_CR47","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.febslet.2004.07.055","volume":"573","author":"R Breitling","year":"2004","unstructured":"Breitling, R., Armengaud, P., Amtmann, A. & Herzyk, P. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett. 573, 83\u201392 (2004).","journal-title":"FEBS Lett."}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-019-0146-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-019-0146-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-019-0146-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T14:33:05Z","timestamp":1671287585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-019-0146-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,9]]},"references-count":47,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["146"],"URL":"https:\/\/doi.org\/10.1038\/s42255-019-0146-4","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737096868.793572985","asserted-by":"object"}]},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,9]]},"assertion":[{"value":"26 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.H., G.P., H.C.G. and G.R.S. hold a patent entitled \u2018Growth differentiation factor 15 as biomarker for metformin\u2019 (WO\/2017\/108941). S.H. and M.K. are employees of Sanofi. All other authors have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}